 | • レポートコード：MRC2210A0077 • 出版社/出版日：Transparency Market Research / 2022年7月 • レポート形態：英文、PDF、194ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、世界の呼吸監視装置市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、製品別（パルスオキシメーター、カプノグラフィー装置、肺機能検査装置、睡眠ポリグラフィ装置（PSG）、ピークフローメーター）分析、エンドユーザー別（在宅医療、病院、外科手術センター、専門クリニック）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況など、以下の項目を掲載しております。本書では、Medtronic、Philips Healthcare（Koninklijke Philips N.V.）、Smiths Medical（part of Smiths Group plc）、Dragerwerk AG＆Co.KGaA、GE Healthcare（part of General Electric Company）、Welch Allyn,Inc.（Hill-Rom Holdings,Inc.）、Masimo、MGC Diagnostics Corporation、Vyaire Medical Inc.（Becton,Dickinson and Company and Apax Partners’ Joint Venture）、Nihon Kohden Corporation、Novelda ASなどの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界の呼吸監視装置市場規模：製品別 - パルスオキシメーターの市場規模 - カプノグラフィー装置の市場規模 - 肺機能検査装置の市場規模 - 睡眠ポリグラフィ装置（PSG）の市場規模 - ピークフローメーターの市場規模 ・世界の呼吸監視装置市場規模：エンドユーザー別 - 在宅医療における市場規模 - 病院における市場規模 - 外科手術センターにおける市場規模 - 専門クリニックにおける市場規模 ・世界の呼吸監視装置市場規模：地域別 - 北米の呼吸監視装置市場規模 - ヨーロッパの呼吸監視装置市場規模 - アジア太平洋の呼吸監視装置市場規模 - 中南米の呼吸監視装置市場規模 - 中東/アフリカの呼吸監視装置市場規模 ・競争状況 |
Respiratory Monitoring Devices Market – Scope of Report
TMR’s report on the global respiratory monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global respiratory monitoring devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global respiratory monitoring devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the respiratory monitoring devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global respiratory monitoring devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global respiratory monitoring devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global respiratory monitoring devices market.
The report delves into the competitive landscape of the global respiratory monitoring devices market. Key players operating in the global respiratory monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global respiratory monitoring devices market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market respiratory monitoring devices.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Respiratory Monitoring Devices Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Technological Advancements
5.2. Prevalence of Asthma & COPD by Region/Country
5.3. Annual Cost of COPD and Asthma
5.4. Key Industry Events (Mergers, Acquisitions, Collaborations, Launch & Approvals, etc.)
5.5. Reimbursement Scenario
5.6. Overview of respiratory disease monitoring in homecare settings
6. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
6.2.1. Pulse Oximeters
6.2.2. Capnographs
6.2.3. Spirometers
6.2.4. Polysomnographs (PSG)
6.2.5. Peak Flow Meters
6.2.6. Gas Analyzers
6.2.7. Others
6.3. Global Respiratory Monitoring Devices Market Attractiveness, by Product
7. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End-user
7.1. Introduction
7.2. Global Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017–2027
7.2.1. Home Care
7.2.2. Hospitals
7.2.3. Ambulatory Surgical Centers
7.2.4. Specialty Clinics
7.3. Global Respiratory Monitoring Devices Market Attractiveness, by End-user
8. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region
8.1. Introduction
8.2. Global Respiratory Monitoring Devices Market Value Forecast, by Region, 2017–2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Respiratory Monitoring Devices Market Attractiveness, by Region
9. North America Respiratory Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.2. North America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
9.2.1. Pulse Oximeters
9.2.2. Capnographs
9.2.3. Spirometers
9.2.4. Polysomnographs (PSG)
9.2.5. Peak Flow Meters
9.2.6. Gas Analyzers
9.2.7. Others
9.3. North America Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017–2027
9.3.1. Home Care
9.3.2. Hospitals
9.3.3. Ambulatory Surgical Centers
9.3.4. Specialty Clinics
9.4. North America Respiratory Monitoring Devices Market Value Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Respiratory Monitoring Devices Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Respiratory Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.2. Europe Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
10.2.1. Pulse Oximeters
10.2.2. Capnographs
10.2.3. Spirometers
10.2.4. Polysomnographs (PSG)
10.2.5. Peak Flow Meters
10.2.6. Gas Analyzers
10.2.7. Others
10.3. Europe Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017–2027
10.3.1. Home Care
10.3.2. Hospitals
10.3.3. Ambulatory Surgical Centers
10.3.4. Specialty Clinics
10.4. Europe Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Respiratory Monitoring Devices Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Respiratory Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
11.2.1. Pulse Oximeters
11.2.2. Capnographs
11.2.3. Spirometers
11.2.4. Polysomnographs (PSG)
11.2.5. Peak Flow Meters
11.2.6. Gas Analyzers
11.2.7. Others
11.3. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017–2027
11.3.1. Home Care
11.3.2. Hospitals
11.3.3. Ambulatory Surgical Centers
11.3.4. Specialty Clinics
11.4. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Respiratory Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
12.2.1. Pulse Oximeters
12.2.2. Capnographs
12.2.3. Spirometers
12.2.4. Polysomnographs (PSG)
12.2.5. Peak Flow Meters
12.2.6. Gas Analyzers
12.2.7. Others
12.3. Latin America Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017–2027
12.3.1. Home Care
12.3.2. Hospitals
12.3.3. Ambulatory Surgical Centers
12.3.4. Specialty Clinics
12.4. Latin America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Respiratory Monitoring Devices Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Respiratory Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027
13.2.1. Pulse Oximeters
13.2.2. Capnographs
13.2.3. Spirometers
13.2.4. Polysomnographs (PSG)
13.2.5. Peak Flow Meters
13.2.6. Gas Analyzers
13.2.7. Others
13.3. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by End-user, 2017–2027
13.3.1. Home Care
13.3.2. Hospitals
13.3.3. Ambulatory Surgical Centers
13.3.4. Specialty Clinics
13.3.5. Hospitals
13.4. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Global Respiratory Monitoring Devices Market Share Analysis, by Company, 2021
14.2. Company Profiles
14.2.1. Medtronic
14.2.1.1. Company Description
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Philips Healthcare (Koninklijke Philips N.V.)
14.2.2.1. Company Description
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Smiths Medical (part of Smiths Group plc)
14.2.3.1. Company Description
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Dragerwerk AG & Co. KGaA
14.2.4.1. Company Description
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. GE Healthcare (part of General Electric Company)
14.2.5.1. Company Description
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)
14.2.6.1. Company Description
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Masimo
14.2.7.1. Company Description
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. MGC Diagnostics Corporation
14.2.8.1. Company Description
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture)
14.2.9.1. Company Description
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Nihon Kohden Corporation
14.2.10.1. Company Description
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Novelda AS
14.2.11.1. Company Description
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis
Table 01: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 09: Europe Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Latin America Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Middle East and Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East and Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Middle East and Africa Respiratory Monitoring Devices Market (US$ Mn) Forecast, by End-user, 2017–2031